Researchers from the University of Hong Kong and Imperial College, London collectively developed a technology that can measure hormones affecting sexual development. With the use of this technology, researchers can also factors affecting menstruation and fertility in a cost-effective manner. Nature Communications has published the study and findings. Researchers tested new robotic sensor technology on patients at Hammersmith Hospital, part of the Imperial College Healthcare NHS Trust.
Groundbreaking Technology could Analyze LH Pulse
In this technology, researchers have used novel biosensor like robotic system called Robotic APTamer-enabled Electrochemical Reader (RAPTER). To measure luteinizing hormone (LH) in blood, they used a prototype RAPTER device that gave results within ten minutes. Until now, measuring LH pulse pattern was difficult, as identifying the pattern needed blood every 10 minutes for eight hours. This process was time-consuming and testing was expensive. This technology is likely to transform clinical care for patients having reproductive disorder by monitoring hormone on a real-time basis. It is highly beneficial in England, where around 33.3% women suffer from acute reproductive health problems such as menopause and infertility.
Researchers also believe that they can create more personalized medicine. Use of this technology can also help in suggesting effective treatments according to the individual’s needs. Reproductive health issues are a global problem, which also affects women mental and physical well-being. However, the team will now work on refining this technology to develop smaller sensor similar to a glucose-monitoring device. With further work, clinicians can use the technology to analyze LH levels in remote or clinical settings. It is likely to be available for use in the next 3-5 years.